. 2021 Mar 22;15:1206. doi: 10.3332/ecancer.2021.1206
© the authors; licensee ecancermedicalscience.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1. Comparison of febrile neutropenia between treatment groups.
